Medytox and its affiliate Numeco said on the 29th that they signed a supply deal with Middle East partner Amico Group for Neuramis and NEWLUX. Neuramis is a hyaluronic acid filler, and NEWLUX is a botulinum toxin product. The company said it will sell products in 10 Middle Eastern countries, including the United Arab Emirates (UAE), Kuwait, and Egypt, in addition to Saudi Arabia, where it already operates.
In the Middle East, average annual exports grew 34% over the past three years. The company secured a minimum purchase volume for three years through this contract. Amico is a distributor that sells pharmaceuticals and medical devices in the Middle East. Medytox and Amico have worked together since 2020.
A Medytox official said, "We will pursue a locally tailored marketing strategy in the Middle East."